Effectiveness of mindfulness‐based cognitive therapy in patients with anxiety disorders in secondary‐care settings: A randomized controlled trial
Akira Ninomiya, Mitsuhiro Sado, Sunre Park, D. Fujisawa, Teppei Kosugi, Atsuo Nakagawa, Joichiro Shirahase, M. Mimura
Psychiatry and Clinical Neurosciences November 27, 2019 DOI: 10.1111/pcn.12960 (opens in new tab) via Semantic Scholar
Summary
AI-generated from the abstractMindfulness-based cognitive therapy (MBCT) helped reduce depression in patients who had not recovered despite prior medication. In a secondary-care setting, patients who received MBCT showed significantly greater improvement in depressive symptoms compared to those receiving treatment as usual. The therapy was especially beneficial for those with more severe or chronic depression. The findings suggest MBCT can be an effective additional treatment for people who have not responded to pharmacotherapy alone.
Study at a glance
| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Population | Patients in secondary-care settings who had undergone pharmacotherapy but not remitted |
| Keywords | Medicine Psychology |
| Key finding | Mindfulness-based cognitive therapy significantly reduced depressive symptoms in patients who had not remitted with prior pharmacotherapy. |
Abstract
The primary objective of this study was to examine the effectiveness of mindfulness‐based cognitive therapy (MBCT) in secondary‐care settings where the vast majority of the patients have already undergone pharmacotherapy but have not remitted.